Midterm Report: Reviewers acknowledge “highly significant achievements”

30 October 2015

Independent reviewers acknowledged the achievements of EU Lead Factory as “highly significant” in the evaluation of the project’s midterm report.

In addition to various very helpful comments, the reviewers emphasized that the EU Lead Factory bridges the gap between academia and pharma, and provides "an avenue to raise the potential for speeding new medicines to patients". For a long-lasting success, the EU Lead Factory will now have to set-up a sophisticated, detailed approach to guarantee sustainability beyond the project period.